The infections by human papillomaviruses (HPVs) are clearly associated with the subsequent development of cervical cancer. In this study, HPV genotype distribution and prevalence were detected in Korean women from January to December 2008 using PCR-DNA sequencing. A total of 2,562 cervical samples from Korean women having routine Pap smear cytology screening were used. HPV DNA was extracted from cervical swab samples and amplified by PCR in L1 region of HPV. HPV DNA was detected in 23.2% and 65.5% from the groups of normal and abnormal Pap cytology, respectively. The prevalence of high-risk types of HPV had the highest frequency in the <30 year-olds' group (50.6%). The prevalence of HPV in normal, ASCUS, LSIL and HSIL groups was 23.2%, 58.1%, 96.3% and 97.0%, respectively. Moreover, the frequencies of the high-risk types of HPV were 16.2% in the normal Pap cytology, 44.7% in the ASCUS, 76.1% in the LSIL and 94.1% in the HSIL groups. The prevalence of the high-risk types of HPV increased in proportion to the severity of the cytological classification. In the HSIL group, HPV type 16 was the most frequently found at 32.4%, followed by types 58, 53 and 33 at 17.6%, 14.7% and 11.8%, respectively. HPV type 82 was found in 5.6% of the HSIL group and was not detected in the normal Pap cytology group. The frequency of high-risk type of HPV 82 is firstly reported in Korean women. This finding could be an informative basis for the development of future HPV vaccination strategies in Korean women.
INTRODUCTION
Cervical cancer is one of the most common malignancies and is the major cause of cancer mortality. Clinical and epidemiological studies have shown that the human papillomaviruses (HPVs) are the major infectious etiologic agents of genital precancerous lesions and cancers (1) . HPVs are strictly epitheliotropic viruses infecting cutaneous or mucosal surfaces and display a very high selectivity for the specific epithelium infected (2) . The persistence of an HPV infection favors viral integration in the cell genome, which, together with other factors, can progress to high-grade, squamous intra-epithelial lesions (HSIL) and cancers (3) .
More than 100 different HPV types have been described, of which at least 30 have been identified in the female genital tract and associated with epithelial neoplasm, ranging from benign common warts to malignant carcinoma of the uterine cervix (4) . HPVs are classified into low-and highrisk categories, based on their association with malignant lesions and phylogenetic relationships (5) . Currently, 19
HPV types, including 16, 18, 26, 30, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73 and 82 are classified as highrisk types (6) . High-risk types have been shown to cause more than 99% of all cases of cervical cancer. Identification 337 of high-risk HPV genotypes may permit selecting those patients who are at an increased risk for disease and may provide additional clinical value (7) .
Knowledge of HPV status is becoming increasingly important as a triage screen after the detection of atypical cells of undetermined significance and as a primary screen for cervical cancer detection. Adequate detection and genotyping are needed to diagnose and study the role of HPV infections in individual patients and patient populations (8) .
Usually, a Pap smear has been used as a cervical cancer screening test. However, the sensitivity of the Pap smear does not exceed 50% (9) . Until now, there has not been a serological test to detect the presence of HPV in cervical specimens (10) . However, sensitive and specific methods are available, based on the detection of HPV DNA, a variety of hybridization techniques, dot blots (11, 12) , reverse hybridization line probe assays (13, 14) , DNA microarray (15~18) and PCR-direct sequencing (19, 20) . A general drawback of hybridization techniques is that they may result in cross-hybridizations of closely related genotypes as well as non-specific hybridization (21, 22) . The DNA sequencing method for HPV genotyping can be applied easily to the analysis of tissue samples and it allows type-specific follow-ups for women who have been treated for cervical intraepithelial neoplasia. To apply the DNA sequencing method in routine clinical laboratory, an expensive machine is required and it will take 2~3 days from request to report (19) . The prevalence of different HPV genotypes depends on the severity of disease, the target population and the geographic area (24) . The aim of this study was to assess the type-specific prevalence of HPV using a sequence-based typing in a Korean population. The association of HPV genotypes with the cytological results was also evaluated. 
MATERIALS AND METHODS

Study populations
HPV PCR
Cervical swab samples were centrifuged at 2,000 g and supernatant was removed. DNA was extracted from 200 μl of concentrated sample using a DNA purification kit (Intron Co., Sungnam, Korea). Viral gene-spin lysis buffer (250 μl) was added to sample and incubated at room temperature for 10 min and 350 μl of binding buffer was added. Lysate was loaded on a spin column and centrifuged at 13,000 rpm for 1 min. After discarding the solution, 500 μl of washing buffer A was added to the column and centrifuged for 1 min at 13,000 rpm. After discarding the solution, 500 μl of washing buffer B was added to the column and centrifuged for 1 min at 13,000 rpm. After discarding the solution, the spin column was placed in a RNase-free 1.5 ml microcentrifuge tube, and elution buffer (30 μl) was directly added onto the membrane and incubated at room temperature for for 45 sec, extension at 72℃ for 45 sec, followed by final extension at 72℃ for 5 min. PCR products were detected by 2% agarose gel electrophoresis. 
Sequencing of PCR products
RESULTS
Prevalence of HPV among age groups
The prevalence of HPV was 50.6%, 39.1%, 37.4% and 34.7% in the <30 year-olds' group, 31~40 year-olds' group, 41~50 year-olds' group and >50 year-olds' group, respectively ( Table 1 ). The prevalence of carcinogenic HPV types and total HPV were the highest in <30 year-olds' group and gradually low in older age groups. Low-risk type HPVs were also frequently found in <30 year-olds' group (10.3%) ( Table 1 ).
Prevalence of HPV in normal and abnormal cytology groups
In the present study, normal and abnormal cytological results with a Pap smear were found in 59.7% and 40.3%, respectively. Invasive cancer sample in cytological examination was not found. As expected, this study shows that women infected with carcinogenic HPV genotypes are at significantly increased risk of having abnormal cytology.
HPV type 16 was the most commonly found genotype in women in both the normal cytology group (3.9%) and the abnormal cytology group (13.8%). Overall HPV prevalence among the 2,562 women included in this analysis was 40.2% (1,031/2,562). Positive rates of HPV were 23.2% and 65.5% in the normal cytology group and the abnormal cytology group, respectively. The high-risk type of HPV was more frequent in the abnormal cytology group (51.3%) than in the normal cytology group (16.2%) ( Table 2) .
Genotype-specific HPV prevalence in cytologically classified groups
The prevalence of HPV in the normal, ASCUS, LSIL (Table 1) . This study showed a continuous decline in the prevalence rates of infections with increasing age. This result was similar as the previous reports from Italy (27) and Germany (9) . The prevalence of HPV increases strongly in the worst-case cytological diagnosis, from 23.2% in the cytological normal group up to 97.0% in the worst Pap classification. The distribution of carcinogenic HPV types in Korean women showed marked differences between the cytologically normal group (16.2%) and the HSIL (94.1%). In particular, the prevalence of HPV type 16 (32.4%) in the HSIL was significantly higher than in the normal cytology group (3.9%) (p < 0.05) ( Table 2 ).
In the present study, carcinogenic HPV was the most frequent in the HSIL group (94.1%), and the prevalence of low-risk types of HPV was the most frequent in the LSIL group (15.3%), and it corresponded to the reports in German people (9) . Some geographical variations in the distribution HPV types have been reported, with frequencies ranging from 3% to 30% or more (6) . In this study, prevalence of In the present study, HPV types 16, 52 and 58 were also found in Korean women. However, HPV types 35 and 39
were not detected in the HSIL group. Moreover, HPV type 18, which is generally considered to be related to calcinogenesis in a previous report (9) , was only found in 2.9% of the HSIL group. It seems that HPV 18 does not have a major role in carcinogenesis of cervical cancer in Korean women.
A mixed infection could be another issue for detecting HPV genotypes. The prevalence of mixed HPV infections by DNA microarray was reported in 20% of the 2,470
Korean women (23) . In the present study, we separated the mixed infections into another group, namely, the uncharacterized group, which accounted for 7.3% of the total women (186/2,562) ( Table 2 ). The persistence of HPV infections bears a high risk for the recurrence of cancer, but only type-specific analysis can differentiate between the true persistence of a specific type or a new HPV infection (20) . Clear identification of HPV genotypes could have important prognostic or therapeutic value, as it can distinguish between HPV types of high and low oncogenic risks.
Updated information on HPV type-specific prevalence in
Korean women is necessary to assess the prevalence of HPV genotypes targeted by available vaccines and to estimate the potential impact of the vaccinations.
